Gasmi Amin, Benahmed Asma Gasmi, Dadar Maryam, Mujawdiya Pavan, Bjorklund Geir
Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.
Académie Internationale de Médecine Dentaire Intégrative, Paris, France.
Curr Med Chem. 2025;32(17):3329-3346. doi: 10.2174/0109298673294083240520044158.
COVID-19 has emerged as the most significant global health issue of our time. The causative agent, SARS-CoV-2, causes extensive damage to the lower respiratory tract in susceptible populations, leading to lung damage and death. COVID-19-infected patients are also prone to respiratory pathogens such as , and . In some cases, these respiratory pathogens are multidrug-resistant and cause life-threatening infections in patients. Since the existing antibiotics are ineffective against these antibiotic-resistant bacteria, urgent attention is required to develop new and effective therapeutic agents to combat antimicrobial-resistant bacteria. Alternatively, novel therapeutic strategies can be explored to enhance the antimicrobial effects of the existing antimicrobial agents, such as antibiotics. Adding natural compounds with existing antimicrobial agents to increase their antimicrobial activity is one of the most suitable and promising options to combat the rising threat of both COVID-19 and antimicrobial resistance. Natural compounds are generally considered safe and may even reduce the side effects of drugs and medicines. In light of such advantages, the current review summarized some of the studies that have combined natural compounds with antibiotics and antiviral to increase the antimicrobial potential of these drugs. This study can help researchers compare and understand already existing data to design new studies to develop antimicrobial agents against COVID-19.
新型冠状病毒肺炎已成为我们这个时代最重大的全球健康问题。病原体严重急性呼吸综合征冠状病毒2(SARS-CoV-2)会对易感人群的下呼吸道造成广泛损害,导致肺损伤和死亡。新型冠状病毒肺炎感染患者还容易感染诸如[此处原文缺失具体病原体名称]等呼吸道病原体。在某些情况下,这些呼吸道病原体具有多重耐药性,并会在患者中引起危及生命的感染。由于现有的抗生素对这些耐药细菌无效,因此迫切需要开发新的有效治疗药物来对抗耐药菌。或者,可以探索新的治疗策略来增强现有抗菌药物(如抗生素)的抗菌效果。将天然化合物与现有抗菌药物联合使用以提高其抗菌活性,是应对新型冠状病毒肺炎和抗菌耐药性不断上升威胁的最合适且最有前景的选择之一。天然化合物通常被认为是安全的,甚至可能减少药物和药品的副作用。鉴于这些优势,本综述总结了一些将天然化合物与抗生素及抗病毒药物联合使用以提高这些药物抗菌潜力的研究。这项研究有助于研究人员比较和理解现有数据,从而设计新的研究来开发针对新型冠状病毒肺炎的抗菌药物。